Immunology resources

Up-to-date information and resources for health professionals to optimise the safety and health outcomes of immunoglobulin for patients with primary immunodeficiencies (PID).

Immunology resources

Key points

  • Immunoglobulin replacement therapy is the leading therapeutic approach for PID with an antibody deficiency.
  • Immunoglobulin dosage should be tailored to meet individual patient needs.
  • Prevention of infection, rather than achieving a particular IgG serum level, should be the goal of therapy for patients with PID.
  • Dosage should be continually reviewed to maximise efficacy while minimising risk of adverse events and costs.
 

Information and resources for health professionals

Clinical Guidance Article (coming soon)
An up-to-date evidence summary on access to immunoglobulin, approved indications and diagnostic challenges among patients with PID.

Case studies (coming soon)
Three hypothetical scenarios in which patients present with PID, or conditions easily mistaken for PID, highlight the complexities of treating patients with immunological conditions.

 

Resources to use with your patients

Immunoglobulin replacement therapy for primary immunodeficiencies
This fact sheet explains how immunoglobulin products can be used to treat PID.

Immunoglobulin management and wellbeing plan
This fillable plan allows patients to keep track of their appointments, treatment and condition.

Moving from paediatric to adult care
This fact sheet highlights important considerations for patients preparing to transition from paediatric to adult care.

Immunoglobulin products: when to reduce or stop treatment
This action plan informs and empowers patients to participate in changes to their treatment.

Immunoglobulin dose adjustment, weaning and cessation: a conversation guide for health professionals
It is common for patients to feel reluctant to make changes to their treatment. This conversation guide supports clinician-led discussions around changes to immunoglobulin treatment plans.

 

e-learning modules

The Australasian Society of Clinical Immunology and Allergy (ASCIA) training course

This course is suitable for healthcare professionals who manage and support patients who have antibody deficiencies and require immunoglobulin replacement therapy.

It is estimated that this course will take up to 60 minutes to complete. Successful completion of the Assessment (Module 5) will provide you with a certificate of completion.

This training has been developed as part of the NPS MedicineWise Value in Prescribing (ViP) Immunoglobulin program. ASCIA also acknowledges the generous support from unrestricted grants for ASCIA education resources and e-training courses, as listed on the ASCIA website.

Hosted by ASCIA.

BloodSafe eLearning Australia

Provides five online Immunoglobulin Patient Blood Management education training courses to support the management and appropriate stewardship of immunoglobulin products.

 

Webinars

<img src=

In this webinar, an experienced and emerging specialist discuss the challenges of prescribing immunoglobulins to patients with immunological conditions.

Hosted by ASCIA.